NEW YORK (GenomeWeb News) – As translational medicine and genetic- and genomic-based diagnostic tests proliferate, some core laboratories that usually support basic research are looking to move into clinical testing. While such a move may make sense for some labs, there are a number of issues that should be considered and addressed, and understanding how such clinical labs are regulated is chief among them.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.